Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1124 | 9675 | 46.2 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
429 | 3 | SPHINGOSINE 1 PHOSPHATE//CERAMIDE//SPHINGOLIPIDS | 27734 |
1124 | 2 | SPHINGOSINE 1 PHOSPHATE//CERAMIDE//SPHINGOLIPIDS | 9675 |
381 | 1 | CERAMIDE//SPHINGOLIPIDS//SPHINGOMYELINASE | 3557 |
431 | 1 | SPHINGOSINE 1 PHOSPHATE//FTY720//SPHINGOSINE KINASE | 3453 |
10439 | 1 | CEREBROSIDE//JASPINE B//PHYTOSPHINGOSINE | 1064 |
11464 | 1 | LONG CHAIN BASE//SPHINGOLIPIDS//AUREOBASIDIN A | 980 |
22171 | 1 | MESOTHERAPY//INJECTION LIPOLYSIS//LIPODISSOLVE | 391 |
27422 | 1 | ALKALINE SPHINGOMYELINASE//BIOMED B11//4 8 SPHINGADIENINE | 230 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SPHINGOSINE 1 PHOSPHATE | authKW | 2154553 | 10% | 73% | 937 |
2 | CERAMIDE | authKW | 2023835 | 14% | 46% | 1387 |
3 | SPHINGOLIPIDS | authKW | 1586769 | 10% | 52% | 965 |
4 | SPHINGOSINE KINASE | authKW | 848859 | 3% | 85% | 316 |
5 | FTY720 | authKW | 846706 | 3% | 80% | 337 |
6 | SPHINGOSINE | authKW | 505134 | 3% | 50% | 321 |
7 | FINGOLIMOD | authKW | 362155 | 2% | 55% | 207 |
8 | SPHINGOMYELINASE | authKW | 323107 | 2% | 45% | 230 |
9 | SPHINGOMYELIN | authKW | 251994 | 3% | 29% | 276 |
10 | SPHINGOSINE KINASE 1 | authKW | 250289 | 1% | 79% | 100 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 19624 | 39% | 0% | 3769 |
2 | Cell Biology | 8928 | 17% | 0% | 1651 |
3 | Biophysics | 3845 | 8% | 0% | 795 |
4 | Chemistry, Medicinal | 2936 | 6% | 0% | 569 |
5 | Chemistry, Organic | 1958 | 8% | 0% | 776 |
6 | Pharmacology & Pharmacy | 1248 | 9% | 0% | 893 |
7 | Immunology | 760 | 6% | 0% | 595 |
8 | Oncology | 608 | 6% | 0% | 611 |
9 | Nutrition & Dietetics | 578 | 3% | 0% | 259 |
10 | Transplantation | 390 | 2% | 0% | 167 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOMEMBRANE BIOFUNCT CHEM | 196634 | 1% | 64% | 98 |
2 | STONY BROOK CANC | 57910 | 0% | 61% | 30 |
3 | UNIT BIOACT MOL RUBAM | 31522 | 0% | 50% | 20 |
4 | CELLULAR MOL REGULAT | 29958 | 0% | 20% | 47 |
5 | U466 | 27019 | 0% | 28% | 31 |
6 | INSERMU466 | 26281 | 0% | 83% | 10 |
7 | UNIT BIOACT MOL | 24452 | 0% | 48% | 16 |
8 | GENET DEV DIS BRANCH | 23342 | 1% | 14% | 52 |
9 | RALPH H JOHNSON VET ADM HOSP | 23223 | 0% | 82% | 9 |
10 | CELLULAR GLYCOBIOL | 22878 | 0% | 48% | 15 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 38264 | 2% | 7% | 181 |
2 | JOURNAL OF LIPID RESEARCH | 12664 | 2% | 2% | 187 |
3 | JOURNAL OF BIOLOGICAL CHEMISTRY | 10736 | 8% | 1% | 750 |
4 | ADVANCES IN LIPID RESEARCH | 6845 | 0% | 16% | 14 |
5 | CELLULAR SIGNALLING | 3627 | 1% | 2% | 72 |
6 | LIPIDS | 3543 | 1% | 1% | 83 |
7 | FASEB JOURNAL | 3335 | 1% | 1% | 103 |
8 | CHEMISTRY AND PHYSICS OF LIPIDS | 2350 | 1% | 2% | 50 |
9 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 2075 | 0% | 2% | 35 |
10 | PROGRESS IN LIPID RESEARCH | 1920 | 0% | 3% | 22 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SPHINGOSINE 1 PHOSPHATE | 2154553 | 10% | 73% | 937 | Search SPHINGOSINE+1+PHOSPHATE | Search SPHINGOSINE+1+PHOSPHATE |
2 | CERAMIDE | 2023835 | 14% | 46% | 1387 | Search CERAMIDE | Search CERAMIDE |
3 | SPHINGOLIPIDS | 1586769 | 10% | 52% | 965 | Search SPHINGOLIPIDS | Search SPHINGOLIPIDS |
4 | SPHINGOSINE KINASE | 848859 | 3% | 85% | 316 | Search SPHINGOSINE+KINASE | Search SPHINGOSINE+KINASE |
5 | FTY720 | 846706 | 3% | 80% | 337 | Search FTY720 | Search FTY720 |
6 | SPHINGOSINE | 505134 | 3% | 50% | 321 | Search SPHINGOSINE | Search SPHINGOSINE |
7 | FINGOLIMOD | 362155 | 2% | 55% | 207 | Search FINGOLIMOD | Search FINGOLIMOD |
8 | SPHINGOMYELINASE | 323107 | 2% | 45% | 230 | Search SPHINGOMYELINASE | Search SPHINGOMYELINASE |
9 | SPHINGOMYELIN | 251994 | 3% | 29% | 276 | Search SPHINGOMYELIN | Search SPHINGOMYELIN |
10 | SPHINGOSINE KINASE 1 | 250289 | 1% | 79% | 100 | Search SPHINGOSINE+KINASE+1 | Search SPHINGOSINE+KINASE+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VOGT, D , STARK, H , (2017) THERAPEUTIC STRATEGIES AND PHARMACOLOGICAL TOOLS INFLUENCING S1P SIGNALING AND METABOLISM.MEDICINAL RESEARCH REVIEWS. VOL. 37. ISSUE 1. P. 3 -51 | 396 | 92% | 0 |
2 | ALSHAKER, H , SAUER, L , MONTEIL, D , OTTAVIANI, S , SRIVATS, S , BOHLER, T , PCHEJETSKI, D , (2013) THERAPEUTIC POTENTIAL OF TARGETING SK1 IN HUMAN CANCERS.ROLE OF SPHINGOLIPIDS IN CANCER DEVELOPMENT AND THERAPY. VOL. 117. ISSUE . P. 143-200 | 284 | 92% | 18 |
3 | TAKABE, K , PAUGH, SW , MILSTIEN, S , SPIEGEL, S , (2008) "INSIDE-OUT" SIGNALING OF SPHINGOSINE-1-PHOSPHATE: THERAPEUTIC TARGETS.PHARMACOLOGICAL REVIEWS. VOL. 60. ISSUE 2. P. 181-195 | 182 | 96% | 300 |
4 | SCHUCHARDT, M , TOLLE, M , PRUFER, J , VAN DER GIET, M , (2011) PHARMACOLOGICAL RELEVANCE AND POTENTIAL OF SPHINGOSINE 1-PHOSPHATE IN THE VASCULAR SYSTEM.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 163. ISSUE 6. P. 1140 -1162 | 235 | 86% | 27 |
5 | BIGAUD, M , GUERINI, D , BILLICH, A , BASSILANA, F , BRINKMANN, V , (2014) SECOND GENERATION S1P PATHWAY MODULATORS: RESEARCH STRATEGIES AND CLINICAL DEVELOPMENTS.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. VOL. 1841. ISSUE 5. P. 745-758 | 163 | 94% | 39 |
6 | WHITE, C , ALSHAKER, H , COOPER, C , WINKLER, M , PCHEJETSKI, D , (2016) THE EMERGING ROLE OF FTY720 (FINGOLIMOD) IN CANCER TREATMENT.ONCOTARGET. VOL. 7. ISSUE 17. P. 23106 -23127 | 199 | 84% | 2 |
7 | PYNE, NJ , PYNE, S , (2010) SPHINGOSINE 1-PHOSPHATE AND CANCER.NATURE REVIEWS CANCER. VOL. 10. ISSUE 7. P. 489 -503 | 155 | 82% | 305 |
8 | HANNUN, YA , OBEID, LM , (2008) PRINCIPLES OF BIOACTIVE LIPID SIGNALLING: LESSONS FROM SPHINGOLIPIDS.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 9. ISSUE 2. P. 139-150 | 95 | 84% | 1190 |
9 | MARFE, G , MIRONE, G , SHUKLA, A , DI STEFANO, C , (2015) SPHINGOSINE KINASES SIGNALLING IN CARCINOGENESIS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 15. ISSUE 4. P. 300 -314 | 178 | 93% | 5 |
10 | ADAN-GOKBULUT, A , KARTAL-YANDIM, M , ISKENDER, G , BARAN, Y , (2013) NOVEL AGENTS TARGETING BIOACTIVE SPHINGOLIPIDS FOR THE TREATMENT OF CANCER.CURRENT MEDICINAL CHEMISTRY. VOL. 20. ISSUE 1. P. 108-122 | 182 | 90% | 22 |
Classes with closest relation at Level 2 |